Back

A prospective analysis of the efficacy and safety of ethacizine during premature atrial contractions and premature ventricular contractions

30 August 2024 (15:00 - 15:50)
Organised by: Logo
Congress Presentation Part of: Drug interactions, efficacy, and safety Antiarrhythmic Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Nika Kuridze

G. Chapidze Emergency Cardiology Center, Tbilisi (Georgia)

7 More presentations in this session

Presentation thumbnail
Adverse cardiovascular outcomes due to potential drug-drug interactions in statin therapy: a population-based study
Ms A. Lai (Shatin, HK)
Abstract Slides Video
Presentation thumbnail
Modulation of p300 acetylation to protect against doxorubicin-induced cardiotoxicity
Mr J. Lee (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Development of a cardiotoxicity evaluation system using a Heart-on-a-Chip Microdevice with aligned fiber device
Doctor K. Murata (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Drug-drug interactions of empagliflozin and dapagliflozin
Professor C. Stoellberger (Wien, AT)
Abstract Slides Video
Presentation thumbnail
Pregnancy protection in women of child-bearing age prescribed ACE inhibitors, ARBs or statins - A nationwide cohort study
Mr S. Nielsen (Hellerup, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Drug interactions, efficacy, and safety

The Event

Event poster

ESC Congress 2024

30 August 2024 15:00 CET
You may be interested in
thumbnail
Congress Presentation
The many NO's to the use of class I antiarrhythmics: does this also apply to ethacizinum?
thumbnail
Congress Presentation
Flecainide in the treatment of high premature ventricular contractions burden: preliminary results from the UNIFLECA study
thumbnail
Congress Presentation
Efficacy and safety of flecainide in patients with reduced ejection fraction and high premature ventricular complex burden: a single-center experience

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources